Zdrowie i gospodarka · 15/08/2025
FDA Announces Public Workshop on Advancing Interchangeable Biosimilar Products
The FDA is hosting a public workshop to discuss and identify future needs for interchangeable biosimilar products, as part of its commitment to the Biosimilar User Fee Act reauthorization.